Evidence map›Paper›PMID 38433286›Full record

ArticleEpidemiology and psychiatric sciences2024

Incidence of mental health diagnoses during the COVID-19 pandemic: a multinational network study.

Yi Chai, Kenneth K C Man, Hao Luo, Carmen Olga Torre, Yun Kwok Wing, Joseph F Hayes, David P J Osborn, Wing Chung Chang, Xiaoyu Lin, Can Yin and 11 more

Open access · goldAbstract read
In one paragraph

Article in Epidemiology and psychiatric sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 6 countries.

Yi ChaiCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.ORCID https://orcid.org/0000-0002-9191-2341
Kenneth K C ManCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.
Hao LuoThe Hong Kong Jockey Club Centre for Suicide Research and Prevention, The University of Hong Kong, Hong Kong.
Carmen Olga TorreCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.
Yun Kwok WingLi Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.
Joseph F HayesDivision of Psychiatry, University College London, London, UK.
David P J OsbornDivision of Psychiatry, University College London, London, UK.
Wing Chung ChangDepartment of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.ORCID https://orcid.org/0000-0002-3581-8895
Xiaoyu LinReal-World Solutions, IQVIA, Durham, NC, USA.
Can YinReal-World Solutions, IQVIA, Durham, NC, USA.
Esther W ChanCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.
Ivan C H LamCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.
Stephen FortinObservation Health Data Analytics, Janssen Research & Development, Titusville, NJ, USA.
David M KernDepartment of Epidemiology, Janssen Research & Development, Titusville, NJ, USA.ORCID https://orcid.org/0000-0001-5417-3925
Dong Yun LeeDepartment of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.
Rae Woong ParkDepartment of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.
Jae-Won JangDepartment of Neurology, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, South Korea.
Jing LiReal-World Solutions, IQVIA, Durham, NC, USA.
Sarah SeagerReal-World Solutions, IQVIA, Durham, NC, USA.
Wallis C Y LauCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.
Ian C K WongCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.
University College London · GBIQVIA (United States) · USAjou University · KRChinese University of Hong Kong · HKHong Kong Jockey Club · CNJanssen (United States) · USCity University of Hong Kong, Shenzhen Research Institute · CNKangwon National University Hospital · KRUniversity of Groningen · NLUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsPopulation-wide restrictions during the COVID-19 pandemic may create barriers to mental health diagnosis. This study aims to examine changes in the number of incident cases and the incidence rates of mental health diagnoses during the COVID-19 pandemic.

methodsBy using electronic health records from France, Germany, Italy, South Korea and the UK and claims data from the US, this study conducted interrupted time-series analyses to compare the monthly incident cases and the incidence of depressive disorders, anxiety disorders, alcohol misuse or dependence, substance misuse or dependence, bipolar disorders, personality disorders and psychoses diagnoses before (January 2017 to February 2020) and after (April 2020 to the latest available date of each database [up to November 2021]) the introduction of COVID-related restrictions.

resultsA total of 629,712,954 individuals were enrolled across nine databases. Following the introduction of restrictions, an immediate decline was observed in the number of incident cases of all mental health diagnoses in the US (rate ratios (RRs) ranged from 0.005 to 0.677) and in the incidence of all conditions in France, Germany, Italy and the US (RRs ranged from 0.002 to 0.422). In the UK, significant reductions were only observed in common mental illnesses. The number of incident cases and the incidence began to return to or exceed pre-pandemic levels in most countries from mid-2020 through 2021.

conclusionsHealthcare providers should be prepared to deliver service adaptations to mitigate burdens directly or indirectly caused by delays in the diagnosis and treatment of mental health conditions.

Indexed as

COVID-19Anxiety DisordersHumansIncidenceMental HealthPandemicsCOVID-19mental healthOHDSIOMOPpsychiatric disorderSARS-CoV-2

Identifiers

PMID38433286
PMCPMC10940053
OpenAlexW4392401196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.